|European School of Urology
|Approx. 60 minutes
Contemporary surgical interventions for prostate cancer (PCa) include radical surgery, radiation and focal therapy. An important factor for patient’s choosing a treatment modality are functional outcomes, including erectile function and continence. Despite this, there is no standardisation in reporting functional outcomes.
Although a number of novel techniques have been introduced to mitigate the risks of erectile dysfunction, there are very few randomised studies assessing the superiority of different surgical interventions on quality-of-life outcomes. Furthermore, arbitrary thresholds are used to report potency and continence rates.
This webinar will critically focus on the quality-of-life outcomes in men treated for PCa following radical prostatectomy. In particular, the speakers will highlight the discrepancies in reported outcome data and real-life setting. They will also provide a model of survivorship care to facilitate return of sexual and urinary function.
In collaboration with Boston Scientific
Contact our organiser
European School of Urology